XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
http://www.dailyhealthindustry.it/fda-multa-di-260-mln-di-dollari-a-grossista-per-contraffazione-di-farmaci-ID7351.html20%Monthly2017-09-29 16:46
http://www.dailyhealthindustry.it/farmaci-oppiodi-stato-di-washington-fa-causa-a-purdue-pharma-ID7349.html20%Monthly2017-09-29 16:36
http://www.dailyhealthindustry.it/ptc-theapeutics-fda-chiede-altri-studi-per-ataluren-distrofia-di-duchenne-ID7347.html20%Monthly2017-09-29 17:52
http://www.dailyhealthindustry.it/abbott-acquista-alere-e-scorpora-tre-strutture-ID7345.html20%Monthly2017-09-29 15:56
http://www.dailyhealthindustry.it/eli-lilly-fda-approva-abemaciclib-tumore-al-seno-ID7343.html20%Monthly2017-09-29 17:55
http://www.dailyhealthindustry.it/accordo-abbvie-amgen-lancio-usa-del-biosimilare-di-humira-nel-2023-ID7339.html20%Monthly2017-09-29 17:12
http://www.dailyhealthindustry.it/boeringher-inghelheim-allo-studio-un-modello-per-i-pazienti-da-trattare-con-jardiance-ID7327.html20%Monthly2017-09-28 16:29
http://www.dailyhealthindustry.it/abbvie-nessun-aumento-dei-prezzi-fino-al-2019-ID7323.html20%Monthly2017-09-28 16:34
http://www.dailyhealthindustry.it/sanofi-regeneron-ok-da-ce-a-dupixent-dermatite-atopica-ID7320.html20%Monthly2017-09-28 17:23
http://www.dailyhealthindustry.it/trump-riforma-sanitaria-rinviata-al-2018-ID7318.html20%Monthly2017-09-28 15:01
http://www.dailyhealthindustry.it/staff-ema-amsterdam-barcellona-o-vienna-per-la-nuova-sede-ID7316.html20%Monthly2017-09-29 06:06
http://www.dailyhealthindustry.it/menarini-da-collaborazione-con-arma-dei-carabinieri-nuova-arma-contro-il-crimine-ID7312.html20%Monthly2017-09-28 16:25
http://www.dailyhealthindustry.it/3m-italia-soluzioni-innovative-per-pazienti-e-operatori-sanitari-ID7305.html20%Monthly2017-09-27 16:47
http://www.dailyhealthindustry.it/assobiomedica-accordo-con-soresa-per-nuovo-modello-acquisti-sanitari-ID7303.html20%Monthly2017-09-27 16:07
http://www.dailyhealthindustry.it/dynavax-pronta-a-lanciare-vaccino-epatite-b-ID7301.html20%Monthly2017-09-27 14:25
http://www.dailyhealthindustry.it/reuters-ecco-le-100-universita-piu-innovative-nessuna-e-italiana-ID7299.html20%Monthly2017-09-27 13:59
http://www.dailyhealthindustry.it/ema-rischio-esodo-impiegati-se-verra-scelta-sede-non-idonea-ID7297.html20%Monthly2017-09-27 13:14
http://www.dailyhealthindustry.it/msd-unaltra-green-light-per-opdivo-fda-dice-si-a-impiego-nel-tumore-gastrico-ID7295.html20%Monthly2017-09-28 13:53
http://www.dailyhealthindustry.it/abbott-ok-da-fda-a-defibrillatore-ellipse-compatibile-con-rm-ID7292.html20%Monthly2017-09-27 12:37
http://www.dailyhealthindustry.it/india-prove-di-sostenibilita-tagli-ai-prezzi-di-stent-e-device-ID7263.html20%Monthly2017-09-26 16:45
http://www.dailyhealthindustry.it/sede-ema-dallimpresa-alla-cultura-un-coro-di-si-per-milano-ID7287.html20%Monthly2017-09-26 17:12
http://www.dailyhealthindustry.it/johnson-johnson-fda-boccia-sirukumab-artrite-reumatoide-ID7284.html20%Monthly2017-09-26 14:48
http://www.dailyhealthindustry.it/pfizer-lancia-start-up-biotech-lavorera-su-farmaci-in-sperimentazione-ID7281.html20%Monthly2017-09-26 14:30
http://www.dailyhealthindustry.it/pharma-pubblicita-in-tv-ai-titoli-di-coda-ID7277.html20%Monthly2017-09-26 14:05
http://www.dailyhealthindustry.it/pfizer-merck-da-ce-via-libera-a-bavencio-uk-e-germania-i-primi-mercati-ID7273.html20%Monthly2017-09-26 10:28
http://www.dailyhealthindustry.it/biogen-arriva-in-italia-daclizumab-scelrosi-multipla-ID7267.html20%Monthly2017-09-25 16:42
http://www.dailyhealthindustry.it/sanofi-pasteur-arriva-vaxigrip-tetra-vaccino-quadrivalente-contro-linfluenza-ID7265.html20%Monthly2017-09-25 15:50
http://www.dailyhealthindustry.it/sede-ema-milano-si-presenta-alla-business-community-internazionale-a-bruxelles-ID7259.html20%Monthly2017-09-25 12:52
http://www.dailyhealthindustry.it/obamacare-mccain-si-mette-di-traverso-verso-il-fallimento-della-riforma-ID7255.html20%Monthly2017-09-25 11:20
http://www.dailyhealthindustry.it/shire-italia-pazienti-e-creativi-insieme-per-app-sulle-malattie-rare-ID7253.html20%Monthly2017-09-25 11:01
http://www.dailyhealthindustry.it/farmaci-galenici-lorenzin-approva-nuove-tariffe-did-vendita-ID7250.html20%Monthly2017-09-25 16:45
http://www.dailyhealthindustry.it/assobiomedica-rinnovati-i-vertici-delle-sei-associazioni-ID7247.html20%Monthly2017-09-25 17:10
http://www.dailyhealthindustry.it/msd-animal-health-a-fianco-dei-veterinari-del-piacenza-wildlife-rescue-center-ID7242.html20%Monthly2017-09-22 16:38
http://www.dailyhealthindustry.it/novartis-ok-da-ue-per-rydapt-leucemia-mieloide-acuta-ID7240.html20%Monthly2017-09-22 16:39
http://www.dailyhealthindustry.it/fda-studi-post-marketing-farmaci-2-su-dieci-non-vengono-effettuati-ID7238.html20%Monthly2017-09-22 14:58
http://www.dailyhealthindustry.it/mylan-aurobindo-e-fondazione-gates-insieme-per-farmaco-innovativo-hiv-in-africa-ID7234.html20%Monthly2017-09-22 16:57
http://www.dailyhealthindustry.it/roche-ce-approva-tocilizumab-per-artrite-a-cellule-giganti-ID7231.html20%Monthly2017-09-22 14:08
http://www.dailyhealthindustry.it/baxter-lancia-primo-sito-web-dedicato-alla-terapia-hdx-emodialisi-ID7229.html20%Monthly2017-09-22 12:43
http://www.dailyhealthindustry.it/fda-gottilieb-stretta-sui-produttori-di-farmaci-galenici-ID7209.html20%Monthly2017-09-21 16:47
http://www.dailyhealthindustry.it/biosimilari-nuove-linee-guida-i-reumatologi-li-giudicano-sicuri-e-affidabili-ID7227.html20%Monthly2017-09-21 16:41
http://www.dailyhealthindustry.it/ai-mercati-emergenti-piacciono-le-big-pharma-ID7224.html20%Monthly2017-09-21 16:14
http://www.dailyhealthindustry.it/teva-il-difficile-compito-del-nuovo-ceo-ID7222.html20%Monthly2017-09-21 16:15
http://www.dailyhealthindustry.it/bms-per-opdivo-ce-il-si-del-nice-ID7220.html20%Monthly2017-09-21 15:03
http://www.dailyhealthindustry.it/sanofi-pronto-anticorpo-trispecifico-per-lhiv-presto-test-sulluomo-ID7217.html20%Monthly2017-09-21 14:11
http://www.dailyhealthindustry.it/amgen-italia-andrea-mantovani-direttore-del-value-e-access-ID7211.html20%Monthly2017-09-21 07:17
http://www.dailyhealthindustry.it/la-francese-neovacs-punta-tutto-su-vaccino-contro-il-lupus-ID7207.html20%Monthly2017-09-20 12:44
http://www.dailyhealthindustry.it/roche-bene-combo-rituximab-venetoclax-in-studio-fase-3-leucemia-linfocitica-cronica-ID7205.html20%Monthly2017-09-20 12:05
http://www.dailyhealthindustry.it/tesaro-panel-ema-raccomanda-niraparib-carcinoma-ovarico-ID7202.html20%Monthly2017-09-20 10:49
http://www.dailyhealthindustry.it/pharma-sudamerica-aggredisce-il-mercato-due-ipo-e-21-fusioni-in-un-anno-ID7200.html20%Monthly2017-09-20 10:30
http://www.dailyhealthindustry.it/astrazeneca-italia-enrica-bucchioni-e-il-nuovo-direttore-medico-ID7197.html20%Monthly2017-09-20 10:52
http://www.dailyhealthindustry.it/aifa-ricerca-indipendente-approvati-finanziamenti-per-40-studi-ID7195.html20%Monthly2017-09-19 15:37
http://www.dailyhealthindustry.it/nabriva-lantibiotico-lefamulin-raggiunge-obiettivo-studio-fase-3-ID7193.html20%Monthly2017-09-19 14:23
http://www.dailyhealthindustry.it/teva-vende-ancora-dopo-paragard-ceduto-lintero-asset-salute-femminile-ID7190.html20%Monthly2017-09-19 13:00
http://www.dailyhealthindustry.it/bayer-da-fda-approvazione-accelerata-per-copanlisib-linfoma-ID7169.html20%Monthly2017-09-19 12:31
http://www.dailyhealthindustry.it/gates-foundation-40-milioni-di-dollari-per-sviluppo-farmaci-contro-malattie-infettive-ID7186.html20%Monthly2017-09-19 11:14
http://www.dailyhealthindustry.it/roche-e-sempre-piu-forte-la-concorrenza-dei-biosimilari-ID7184.html20%Monthly2017-09-19 11:01
http://www.dailyhealthindustry.it/usa-nel-maryland-prima-legge-contro-rincaro-prezzo-farmaci-ID7179.html20%Monthly2017-09-18 16:42
http://www.dailyhealthindustry.it/janssen-chmp-raccomanda-tremfya-psoriasi-ID7175.html20%Monthly2017-09-18 15:30
http://www.dailyhealthindustry.it/bayer-ce-approva-rivaroxaban-in-associazione-ad-antiaggregante-piastrinico-fibrillazione-atriale-ID7173.html20%Monthly2017-09-18 14:35
http://www.dailyhealthindustry.it/gsk-primo-si-dellema-a-tripla-combo-per-bpco-ID7171.html20%Monthly2017-09-18 16:44
http://www.dailyhealthindustry.it/sanita-usa-calano-le-iscrizioni-ad-aca-aumentano-i-premi-delle-assicurazioni-ID7167.html20%Monthly2017-09-18 12:33
http://www.dailyhealthindustry.it/samsung-biopis-ok-ema-a-ontruzant-biosimilare-di-herceptin-roche-ID7165.html20%Monthly2017-09-18 16:28
http://www.dailyhealthindustry.it/pfizer-e-astellas-xtandi-cancro-alla-prostata-aumenta-i-tassi-di-sopravvivenza-ID7161.html20%Monthly2017-09-18 16:10
http://www.dailyhealthindustry.it/takeda-parte-la-sperimentazione-del-vaccino-contro-la-dengue-ID7157.html20%Monthly2017-09-15 13:30
http://www.dailyhealthindustry.it/amgen-ok-da-fda-a-mvasi-biosimilare-di-avastin-roche-ID7155.html20%Monthly2017-09-15 16:34
http://www.dailyhealthindustry.it/eli-lilly-nuove-prospettive-per-baricitinib-nel-trattamento-delleczema-ID7152.html20%Monthly2017-09-15 11:01
http://www.dailyhealthindustry.it/smith-nephew-accordo-con-imperial-college-per-chirurgia-del-ginocchio-ID7149.html20%Monthly2017-09-15 10:36
http://www.dailyhealthindustry.it/depuy-fda-autorizza-impianti-in-titanio-3d-per-chirurgia-maxillo-facciale-ID7147.html20%Monthly2017-09-15 10:28
http://www.dailyhealthindustry.it/usa-prezzi-dei-farmaci-una-lettera-a-jama-accende-i-fari-su-un-ormone-ID7140.html20%Monthly2017-09-14 15:01
http://www.dailyhealthindustry.it/bridgebio-pharma-135-milioni-per-ricerca-sulle-malattie-genetiche-ID7137.html20%Monthly2017-09-14 15:46
http://www.dailyhealthindustry.it/sanofi-e-regeneron-dupilumab-raggiunge-endpoint-in-studio-sullasma-ID7134.html20%Monthly2017-09-14 14:37
http://www.dailyhealthindustry.it/teva-cede-il-primo-brand-il-contraccettivo-paragard-passa-a-copper-ID7132.html20%Monthly2017-09-14 15:59
http://www.dailyhealthindustry.it/msd-11-milioni-di-dollari-per-piattaforma-trial-clinici-ID7130.html20%Monthly2017-09-14 13:49
http://www.dailyhealthindustry.it/gsk-panel-fda-raccomanda-vaccino-shingrix-herpes-zoster-agli-adulti-over-50-ID7128.html20%Monthly2017-09-14 16:03
http://www.dailyhealthindustry.it/ge-healthcare-arriva-in-italia-nuovo-mezzo-di-contrasto-per-rm-ID7125.html20%Monthly2017-09-13 16:55
http://www.dailyhealthindustry.it/obamacare-il-nodo-e-sui-contributi-alle-assicurazioni-ID7123.html20%Monthly2017-09-13 16:46
http://www.dailyhealthindustry.it/gsk-il-vaccino-mosquirix-testato-in-quattro-formulazioni-ID7120.html20%Monthly2017-09-13 15:46
http://www.dailyhealthindustry.it/fondazione-gates-120-milioni-di-dollari-per-ricerca-vaccini-ID7118.html20%Monthly2017-09-13 15:33
http://www.dailyhealthindustry.it/roche-pirfenidone-fibrosi-polmonare-sicuro-in-associazione-e-in-monoterapia-ID7116.html20%Monthly2017-09-13 15:13
http://www.dailyhealthindustry.it/fda-gottlieb-trial-piu-snelli-per-migliorare-i-processi-regolatori-dei-farmaci-ID7113.html20%Monthly2017-09-13 14:55
http://www.dailyhealthindustry.it/msd-keytruda-efficace-anche-nel-tumore-allo-stomaco-ID7111.html20%Monthly2017-09-12 15:13
http://www.dailyhealthindustry.it/roche-italia-e-regione-puglia-insieme-per-progetto-di-assessment-in-oncoematologia-ID7109.html20%Monthly2017-09-12 14:36
http://www.dailyhealthindustry.it/sanofi-e-regeneron-breakthrough-therapy-per-cemiplimab-carcinoma-cutaneo-ID7107.html20%Monthly2017-09-12 12:44
http://www.dailyhealthindustry.it/astrazeneca-e-amgen-bene-tezepelumab-biologico-per-lasma-ID7105.html20%Monthly2017-09-12 12:24
http://www.dailyhealthindustry.it/eli-lilly-con-abemaciclib-tumore-al-seno-inizia-il-rilancio-ID7103.html20%Monthly2017-09-12 10:54
http://www.dailyhealthindustry.it/teva-kare-shultz-e-il-nuovo-ceo-una-carriera-tra-lundbeck-e-novo-nordisk-ID7098.html20%Monthly2017-09-12 10:38
http://www.dailyhealthindustry.it/roche-vemurafenib-piu-efficace-del-placebo-nella-dfs-ID7092.html20%Monthly2017-09-11 15:39
http://www.dailyhealthindustry.it/msd-con-keytruda-rischio-di-morte-ridotto-del-30-per-cento-nel-carcinoma-uroteliale-ID7090.html20%Monthly2017-09-11 14:23
http://www.dailyhealthindustry.it/roche-pronto-test-ematico-per-personalizzare-terapie-oncologiche-ID7088.html20%Monthly2017-09-11 12:39
http://www.dailyhealthindustry.it/aifa-in-cinque-anni-31-molecole-innovative-contro-il-cancro-ID7086.html20%Monthly2017-09-11 16:05
http://www.dailyhealthindustry.it/astrazeneca-tagrisso-nuovo-standard-di-cura-per-tumore-al-polmone-ID7082.html20%Monthly2017-09-11 10:50
http://www.dailyhealthindustry.it/astrazeneca-e-celgene-stop-della-fda-a-cinque-trials-su-combo-con-imfinzi-ID7079.html20%Monthly2017-09-08 16:47
http://www.dailyhealthindustry.it/eli-lillly-dal-2018-via-ai-licenziamenti-se-ne-prevedono-3500-ID7077.html20%Monthly2017-09-08 15:52
http://www.dailyhealthindustry.it/roche-priority-review-per-emicizumab-nellemofilia-a-con-inibitori-ID7075.html20%Monthly2017-09-08 15:28
http://www.dailyhealthindustry.it/mylan-problemi-per-epipen-interviene-fda-ID7073.html20%Monthly2017-09-08 14:30
http://www.dailyhealthindustry.it/fda-warning-letter-a-produttore-di-oppiodi-e-scoppia-la-polemica-ID7069.html20%Monthly2017-09-08 14:21
http://www.dailyhealthindustry.it/bms-combo-opdivo-yervoy-centra-obiettivo-prima-del-tempo-nel-tumore-renale-ID7067.html20%Monthly2017-09-11 15:46
http://www.dailyhealthindustry.it/malattie-rare-la-fda-decide-su-volanesorsen-ionis-ID7063.html20%Monthly2017-09-07 17:18
http://www.dailyhealthindustry.it/pharma-usa-riprende-loccupazione-ID7061.html20%Monthly2017-09-07 17:08
http://www.dailyhealthindustry.it/verastem-duvelisib-linfoma-raggiunge-obiettivo-studio-entro-meta-2018-domanda-fda-ID7059.html20%Monthly2017-09-07 17:01
http://www.dailyhealthindustry.it/novartis-kymriah-la-vera-innovazione-che-va-oltre-laccessibilita-ID7057.html20%Monthly2017-09-07 16:50
http://www.dailyhealthindustry.it/roche-alecensa-tumore-al-polmone-convince-nel-trial-ID7055.html20%Monthly2017-09-07 16:44
http://www.dailyhealthindustry.it/pfizer-lancia-videogioco-per-giovani-pazienti-con-emofilia-ID7053.html20%Monthly2017-09-07 15:45
http://www.dailyhealthindustry.it/sanofi-u-s-army-si-sfila-da-collaborazione-su-vaccino-contro-zika-virus-ID7047.html20%Monthly2017-09-06 16:19
http://www.dailyhealthindustry.it/sanofi-italia-salute-e-smart-working-nel-nuovo-accordo-integrativo-ID7044.html20%Monthly2017-09-06 14:52
http://www.dailyhealthindustry.it/merck-kgaa-vende-la-bu-consumer-ID7042.html20%Monthly2017-09-06 14:33
http://www.dailyhealthindustry.it/novo-nordisk-accordo-con-dipartimento-giustizia-usa-per-vicenda-victoza-ID7040.html20%Monthly2017-09-06 14:09
http://www.dailyhealthindustry.it/obamacare-riprende-il-dibattito-negli-usa-ID7038.html20%Monthly2017-09-06 13:33
http://www.dailyhealthindustry.it/abbvie-aifa-approva-rimborsabilita-di-venclyxto-venetoclax-ID7036.html20%Monthly2017-09-06 13:08
http://www.dailyhealthindustry.it/adherium-ok-fda-a-inalatore-per-symbicort-astrazeneca-ID7030.html20%Monthly2017-09-05 15:38
http://www.dailyhealthindustry.it/destiny-pharma-scommette-su-antibiotico-ultima-generazione-e-firma-accordo-con-la-cina-ID7027.html20%Monthly2017-09-05 15:22
http://www.dailyhealthindustry.it/sanofi-premio-zanibelli-ecco-la-terna-dei-finalisti-ID7023.html20%Monthly2017-09-05 15:06
http://www.dailyhealthindustry.it/daichii-sankyo-fine-della-collaborazione-con-charleston-per-candidato-dolore-ID7020.html20%Monthly2017-09-05 13:57
http://www.dailyhealthindustry.it/bayer-punta-sullemofilia-a-fda-richiesta-per-candidato-a-lunga-durata-dazione-ID7018.html20%Monthly2017-09-05 13:00
http://www.dailyhealthindustry.it/novartis-il-nuovo-ceo-e-vas-narasimhan-ID7015.html20%Monthly2017-09-05 17:56
http://www.dailyhealthindustry.it/pfizer-disco-verde-fda-per-mylotarg-leucemia-mieloide-acuta-ID7013.html20%Monthly2017-09-04 15:17
http://www.dailyhealthindustry.it/otonomy-fallisce-studio-per-farmaco-malattia-di-meniere-ID7011.html20%Monthly2017-09-04 14:47
http://www.dailyhealthindustry.it/gileadnovartis-testa-a-testa-nella-sfida-car-t-ID7009.html20%Monthly2017-09-04 14:20
http://www.dailyhealthindustry.it/3m-fda-estende-indicazioni-tegaderm-a-infezioni-catetere-correlate-ID7006.html20%Monthly2017-09-04 13:30
http://www.dailyhealthindustry.it/astrazeneca-nice-respinge-faslodex-il-4-ottobre-nuovo-pronunciamento-ID7004.html20%Monthly2017-09-04 13:48
http://www.dailyhealthindustry.it/mylan-e-biocon-fda-rinvia-al-3-dicembre-decisione-su-biosimilare-herceptin-roche-ID7002.html20%Monthly2017-09-04 10:40
http://www.dailyhealthindustry.it/brexit-lonu-teme-per-la-tenuta-socio-sanitaria-fari-accesi-sui-diritti-delle-persone-disabili-ID7000.html20%Monthly2017-09-01 14:15
http://www.dailyhealthindustry.it/astrazeneca-bene-studi-pacific-e-flaura-tumore-al-polmone-ID6998.html20%Monthly2017-09-01 13:18
http://www.dailyhealthindustry.it/stada-claudio-albrecht-nuovo-ceo-e-il-quarto-in-un-anno-ID6994.html20%Monthly2017-09-01 12:52